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Toll-like receptors (TLRs) have previously been
shown to play critical roles in the activation of innate
immunity. Here, we describe that T cell expression of
TLR2 regulates T helper 17 (Th17) cell responses.
Stimulation with TLR2 agonists promoted Th17
differentiation in vitro and led tomore robust prolifer-
ation and Th17 cytokine production. Using the exper-
imental autoimmune encephalomyelitis (EAE) model,
we found that TLR2 regulated Th17 cell-mediated
autoimmunity in vivo and that loss of TLR2 in CD4+
T cells dramatically ameliorated EAE. This study
thus reveals a critical role of a TLR in the direct
regulation of adaptive immune response and patho-
genesis of autoimmune diseases.
INTRODUCTION
Toll-like receptors (TLRs) function in the ‘‘first line of defense’’
against various infectious agents. As evolutionarily conserved
pattern recognition receptors, TLRs recognize distinct microbial
products. Upon binding to their cognate ligands, TLRs activate
the innate immune response, leading to the production of proin-
flammatory cytokines and chemokines (Kawai and Akira, 2007).
These receptors also stimulate maturation of dendritic cells and
the expression of costimulatory molecules on antigen-present-
ing cells (APCs) to facilitate the activation of adaptive immunity
(Janeway and Medzhitov, 2002). Recently, TLRs have been
found to directly activate the innate function of gd T cells, result-
ing in the production of the cytokines interleukin-17 (IL-17) and
IL-22 (Martin et al., 2009). Although generally thought to regulate
adaptive immunity indirectly through the activation of innate
responses, TLRs have been also reported to modulate the func-
tion of T lymphocytes as well (reviewed in MacLeod andWetzler,
2007). TLR2, in particular, has been shown by multiple groups to
be expressed by and to function in CD4+ T lymphocytes. For
example, TLR2 was found to provide a costimulatory signal on
activated CD4+ T helper cells (Komai-Koma et al., 2004). Further-
more, TLR2 engagement in CD8+ T cells enhanced proliferation,692 Immunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc.activation, and memory cell formation even under suboptimal
activation conditions (Cottalorda et al., 2006; Mercier et al.,
2009). TLR2 has also been shown to be functional directly on
regulatory T cells (Chen et al., 2009; Liu et al., 2006). Thus, ab
T cells appear to directly express TLRs; however, the physiolog-
ical and pathological significance of TLR expression in antigen-
specific T cells remains unclear.
Naive CD4+ T helper (Th) cells, upon activation by the innate
immune system, differentiate into distinct effector lineages de-
pending on the environmental signals present during activation
(Dong and Flavell, 2000; Glimcher and Murphy, 2000). Recently,
Th17 cells have been identified and characterized as a distinct
T cell lineage mediating tissue inflammation, especially in auto-
immunity (Dong, 2006; Weaver et al., 2006). In addition to activa-
tion through T cell receptor (TCR) and costimulatory receptors,
Th17 cells require distinct factors for their development and
maintenance, including transforming growth factor beta
(TGFb), IL-6, IL-21, IL-1b, and IL-23 (Chung et al., 2009; Dong,
2008). Th17 cells and IL-17 activity has been attributed to the
pathogenesis of a variety of autoimmune disorders, including
experimental autoimmune encephalomyelitis (EAE), an animal
model of multiple sclerosis (MS) (Langrish et al., 2005; Park
et al., 2005; Yang et al., 2008a).
Previously, TLR2 function has been linked to central nervous
system (CNS) inflammation. During EAE, TLR2 along with poly
(ADP-ribose) polymerase 1 expression on macrophages and
astrocytes was found to promote CNS inflammation (Farez
et al., 2009). In this study, we investigated the direct role of
TLR2 in the generation and function of Th17 cells in vitro and
in vivo. We found that TLR2 activation during Th17 differentiation
enhanced proliferation and Th17 cytokine production. More
importantly, deficiency of TLR2 in CD4+ T cells substantially
impaired Th17 responses in vivo and the pathogenesis of EAE.
Therefore, TLR2 directly regulates Th17 responses and Th17-
mediated autoimmune disease.
RESULTS
TLR2 Signaling in T Cells Enhances Th17 Differentiation
In an attempt to identify genes that are differentially expressed
in Th1 and Th17 cells, we performed microarray analysis and
found that TLR2 was more highly expressed by Th17 cells
Figure 1. TLR Expression in Th17 Cells
(A) Expression of various TLRs on Th1, Th2, and Th17 cells following 4 day
differentiation. Bone marrow-derived macrophages and IL-17-producing gd
T cells were utilized as positive controls. Relative mRNA expression was
compared by setting the lowest expression amount to an arbitrary value of 1.
(B) Expression of TLRs on ab and gd T cells following IL-23 time point stimula-
tion. 20 ng/ml IL-23 was added to sorted splenic CD4+ and gd T lymphocytes,
and cells were lysed at 0, 2, 4, 6, 8, 16, and 24 hr post-IL-23 stimulation.
Unstimulated cells served as the expression baseline. For all experiments,
data are presented as mean ± SD and are a representative of at least two inde-
pendent experiments. All gene quantities were normalized to the expression of
the reference gene b-actin.
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TLR2 Regulates Th17 Responses(GEO accession number GSE11924). To further investigate TLR
expression in T cell subsets, we performed real-time RT-PCR on
Th1, Th2, and Th17 subsets using bone marrow-derived macro-
phages and RFP+ gd T cells from IL-17F-RFP reporter mice as
positive controls. It has previously been shown that TLR2
signaling requires heterodimerization with TLR1 or TLR6 (Schu-
mann and Tapping, 2007). In accordance, TLR1, -2, and -6
mRNAs were expressed to the highest degree in Th17 cells
compared to Th1 and Th2 subsets (Figure 1A and Figure S1A
available online). TLR4 expression was also found to be
enhanced in Th17 cells, whereas TLR9 expression was similar
between Th2 and Th17 cells. To further analyze TLR expression
in Th subsets, we stained various effector T cells (either left
untreated or activated through TLR2) with anti-TLR2 for flow
cytometry. Th17 cells exhibited positive staining, although to
a much lower degree compared to a macrophage control (Fig-
ure S1B). Treatment with a TLR2 -TLR1 ligand, Pam3Cys-Ser-
(Lys)4-trihydrochloride (Pam3Cys), however, induced TLR2
expression in Th2 cells. Recently, the expression of TLR2 and
-4 was found to be enhanced in IL-17-producing gd T cells
(Martin et al., 2009). Although we consistently observed upregu-
lated TLR expression in Th17 cells compared to other types of Th
cells, there was much greater expression of various TLRs in
IL-17-producing gd T cells. Thus, our results suggest that similar
to these innate T cells, Th17 cells may be able to respond to
pathogen-associated molecules.
Because IL-23 is important in IL-17 responses in both ab and
gd T cells (Langrish et al., 2005; O’Brien et al., 2009), we next
investigated whether TLR2 can influence IL-23 expression and
vice versa. TLR2 activation of bone marrow-derived macro-
phages and dendritic cells resulted in substantially increased
IL-23 p19 mRNA expression (Figure S1C). Moreover, IL-23 stim-
ulation of gd, but not ab, T cells led to enhanced TLR1, -2, and -4
mRNA expression in a time-dependent manner (Figure 1B). As
we will address later (Figure 4B), IL-23 is not sufficient by itself
to drive gd T cell proliferation, so IL-23 was unlikely expanding
a subpopulation of IL-17-producing gd T cells in these experi-
ments.
Considering the TLR2 expression observed in Th17 cells, we
next investigated if TLR2 activation in CD4+ T cells in vitro could
modulate Th17 differentiation and/or function. FACS-sorted
naive CD4+ T cells were cultured with plate-bound anti-CD3
and anti-CD28 in the presence of TGFb and IL-6, along with
blocking antibodies against IFNg and IL-4. A TLR2 ligand,
Pam3Cys, was added to the differentiation media in some cases
as well. Cells differentiated in the presence of Pam3Cys
exhibited an 50% increase in IL-17 single-positive and IL-17-
IL-17F double-positive cells (Figure 2A). IFNg was not detected
in either group (data not shown). ELISA analysis of primary
culture supernatants, as well as those from effector Th17 cells
restimulated with anti-CD3 overnight, revealed a similar
enhancement of IL-17 and IL-17F production in cells cultured
in the presence of TLR2 stimuli (Figure 2B). We further examined
whether this effect was TLR2-specific by using TLR2-deficient
naive CD4+ T cells. TLR2-deficient (Tlr2/) T cells did not exhibit
obvious differences in Th17 polarization in the absence of exog-
enous TLR2 ligands compared to WT controls; however, the
number of IL-17-producing cells did not substantially increase
following stimulation with the Pam3Cys ligand (Figure 2C).Immunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc. 693
Figure 2. Enhanced Th17 Differentiation
Following TLR2 Activation
(A) Intracellular cytokine staining following 4 day
Th17 differentiation in the absence (left) or pres-
ence (right) of Pam3Cys. Each panel represents
cells derived from an individual mouse, and two
mice were used for each treatment group.
(B) ELISA analysis of supernatants from primary
4 day differentiation (left) or overnight anti-CD3
only restimulated (right) cultures. All groups are
analyzed in triplicate and are presented here as
the mean ± SD from three individual mice per
group.
(C) Th17 differentiation was performed as in (A)
using naive T cells derived from WT and Tlr2/
animals.
(D) mRNA expression of naive and Th17 cells
differentiated in the absence or presence of
Pam3Cys. Each bar represents mean ± SD values
obtained from T cells of three individual mice.
Naive T cell gene expression was used as the
baseline of expression, and all gene quantities
were normalized to the expression of b-actin.
*Student’s t test; p < 0.05. All data are a represen-
tative of at least three individual experiments.
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APCs may be the cause of increased Th17 differentiation upon
TLR2 ligand treatment; dendritic cells or macrophages activated
through TLR2 could produce such factors as IL-23 that could, in
turn, amplify the Th17 response. To address this, we performed
Th17 differentiation of naive CD4+ T cells derived from WT and
IL-23-deficient (Il23a/) animals that were first depleted of
APCs and then selected for CD4+ expression. The production
of IL-17 and IL-17F and the frequency of Th17 cells were
increased in the cultures that were stimulated with TLR2 ligands,
whereas no real differences were observed between T cells
derived from Il23a/ animals compared toWT controls. Further-
more, IL-1b or IL-23 was not detected above background in all
Th17 culture conditions analyzed (Figure S2A and S2B). More-
over, CD11c expression was not detectable above background
in our purified T cells (Figure S2C). Finally, we performed Th17
differentiations in the absence or presence of increasing concen-
trations of LPS and speculated that if TLR2 ligand treatment was,
in fact, activating contaminating APCs rather than naive T cells,
then LPS treatment would do the same. The production of
IL-17 and IL-17F remained unchanged after LPS treatment
compared to untreated controls (Figure S2D), ruling out contam-
ination of APCs.694 Immunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc.TLR2 Activation Induces
Th17-Related Genes
To assess the mechanism whereby TLR2
enhances Th17 cytokine production, we
compared the gene expression of CD4+
T cells differentiated under Th17 condi-
tions in the absence or presence of
Pam3Cys. Consistent with the protein
results, upregulation of Th17-associated
mRNA (IL-17, IL-17F, IL-21, and CCR6)
was also detected (Figure 2D). The tran-scription factors RORg and RORa are critical in regulating the
Th17 cell genetic programming (Yang et al., 2008c). Moreover,
IRF-4 and AhR have recently been identified as Th17-promoting
transcription factors (Bru¨stle et al., 2007; Veldhoen et al., 2008).
Analysis of these genes revealed an enhancement of RORg,
RORa, and IRF-4 mRNA expression upon TLR2 engagement
(Figure 2D), suggesting a direct role of TLR signaling in the
expression of critical Th17-regulating transcriptional factors. It
seems that the amounts of T-bet mRNA in this experiment
were higher in the naive T cell population than in the test popu-
lation; however, if compared directly to Th1 cells, naive cells
actually expressed miniscule amounts of T-bet. To determine
if increased Th17 cytokine expression by TLR2 activation
was a result of an increase in the number of Th17 cells, we per-
formed a similar experiment using our IL-17F-RFP reporter mice
(Yang et al., 2008b). Naive T cells from these mice were differ-
entiated in the presence or absence of Pam3Cys. RFP+ cells
were then sorted, and mRNA quantification was performed.
RFP+ cells that were activated through TLR2 exhibited similar
increases in expression of Th17-related factors (Figure S2E),
suggesting that TLR2 signaling enhances Th17 differentiation
on a per cell basis rather than simply expanding the Th17
population.
Figure 3. Proliferation of Th17 Cells following TLR2 Engagement
(A) Assessment of total cell numbers following Th17 differentiation in the
presence or absence of Pam3Cys. Each bar represents T cells derived from
two individual mice. *Student’s t test; p < 0.05.
(B) CFSE staining of Th17 cells following 4 days of differentiation in the
absence (left) or presence (right) of Pam3Cys. Numbers shown in each gate
are indicative of mean fluorescent intensity. Data are a representative of four
independent experiments.
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Previous studies have demonstrated that both activated CD4+
and CD8+ T cells proliferate more extensively upon TLR2 activa-
tion (Cottalorda et al., 2006; Komai-Koma et al., 2004). Indeed,
developing Th17 cells proliferated 2-fold more extensively
when Pam3Cys was included in the differentiation media than
those cultured without Pam3Cys by total cell counts following
4 days of differentiation (Figure 3A). Likewise, using carboxy-
fluorescein diacetate succinimidyl ester (CFSE) to determine
proliferation of differentiating Th17 cells, we demonstrated that
more cells were in the later stages of division after TLR2 activa-
tion compared to cells differentiated without TLR2 ligand (Fig-
ure 3B). Taken together, our data suggest that TLR2 can directly
regulate the differentiation of Th17 cells and their expansion
in vitro.
TLR2 Signaling Enhances Proliferation and IL-17
Production by Effector, Memory, and gd T cells
Because TLR2 activation enhanced Th17 cytokine production
and proliferation of naive CD4+ T cells when they were polarized
to Th17 cells, we next investigated whether TLR2 stimulation
could influence the function of other types of T lymphocytes.
To address this possibility, we first investigated TLR2 activity
on fully differentiated Th17 cells. Following 4 day in vitro differen-tiation, Th17 cells were restimulated in the absence or presence
of various TLR ligands in the absence of TCR activation. IL-17
and IL-22 production was then assessed by ELISA. We found
that treatment of fully differentiated Th17 cells with most TLR
ligands alone (except for polyI:C) enhanced both IL-17 and
IL-22 production compared to untreated cells (Figure 4A). More-
over, IL-23 and TLR agonists synergistically enhanced the
production of these Th17 cytokines. Of all the conditions tested,
the combination of TLR2 and IL-23 was one of the strongest in
inducing IL-17 and IL-22 production. TLR4 activation, in combi-
nation with IL-23, has recently been shown to induce IL-17 in gd
T cells (Martin et al., 2009). Here, we observed a similar effect of
LPS in the promotion of IL-17, but not IL-22, production in ab
T cells both in the presence or absence of IL-23.
The TLR2-IL-23 synergy observed on Th17 cells was further
extended to other T cell subsets. As shown in a previous report
(Martin et al., 2009), we found that gd T cells, in the absence of
TCR stimulation, exhibited a strong IL-17-specific response
when treated with IL-23 alone (data not shown); however, very
little IL-17 production was observed in cells treated with only
Pam3Cys. Moreover, similar to differentiated Th17 cells, gd
T cells treated with a combination of IL-23 and Pam3Cys
exhibited the highest degree of IL-17 production. TLR2-deficient
gd T cells failed to exhibit this synergy, and their IL-17 production
in response to IL-23 alone was reduced as well. Additionally,
although not on the same scale as gd T cells, memory T cells
also produced IL-17 in a synergistic fashion following Pam3Cys
and IL-23 treatment in the absence of TCR stimulation
(Figure S3).
We next investigated the contributions of TLR2 and IL-23 on
cellular proliferation in the absence of TCR stimulation. TLR2
stimulation alone was found to be sufficient for the proliferation
of gd T cells; 50% of gd T cells divided following 2 day stimula-
tion (Figure 4B). Naive and memory cells were also expanded
in response to Pam3Cys alone without TCR activation, albeit
to a reduced degree compared to gd T cells, possibly due to their
reduced TLR2 expression. The proliferative effect of the
Pam3Cys observed here was directly dependent on TLR2 sig-
naling as TLR2-deficient T lymphocytes failed to expand (Fig-
ure 4C). Surprisingly, IL-23 stimulation had little to no effect on
the proliferation of all T cells tested, suggesting that TLR2 stim-
ulation may drive proliferation, where IL-23 is only essential for
regulating IL-17 differentiation programs.
We have previously shown that Th17 cells derived from naive
TLR2-deficient T cells do not have intrinsic defects in IL-17
production (Figure 2C). Next, we decided to examine if the
same were true for gd T cells. Interestingly, we found that
TLR2-deficient gd T cells exhibited decreased IL-17 expression
in response to IL-23 alone in adult gd T cells from peripheral
lymphoid tissues (data not shown). Therefore, to examine the
possibility that TLR2-deficient gd T cells may have an intrinsic
defect in IL-17 production, we harvested both peripheral gd
T cells and embryonic thymocytes derived from WT and TLR2-
deficient animals, stimulated with PMA and ionomycin, and
then measured IL-17 production (Figure 5A). Adult gd T cells
derived from the spleen of TLR2-deficient animals on a C57BL/
6 background exhibited a reduced capacity for IL-17 production;
however, no difference was observed in embryonic thymus
between the two groups, indicating that TLR2 gd T cells developImmunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc. 695
Figure 4. The Effect of TLR2 Activation in
Combination with IL-23 on ab and gd T Cells
(A) Overnight activation of Th17 cells with various
TLR ligands following 4 day differentiation. The
production of IL-17 (top) and IL-22 (bottom) was
assessed in triplicate by ELISA. *Student’s t test,
p < 0.05. *Significant comparison of samples
without IL-23 to untreated control. **Significant
comparison of samples treated with IL-23 to
untreated IL-23 samples and untreated controls.
(B) CFSE labeling of sorted naive CD4+, memory
CD4+, and gd T cells following 2 day stimulation
with TLR2 agonist or IL-23. Data are representa-
tive of three individual experiments.
(C) CFSE labeling of sorted total CD4+ T cells (left)
and gd T cells (right) derived from WT (top) and
Tlr2/ (bottom) animals. Data are a representative
of three independent experiments. Numbers
shown in each gate are indicative of mean fluores-
cent intensity.
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maturation. Likewise, IL-23-deficient gd T cells on a C57BL/6 3
129 mixed background derived from spleen or lung exhibited
greatly decreased IL-17 production as well upon PMA plus
ionomycin restimulation (Figure 5B). Although IL-23 has been
shown to be important in IL-17 expression by gd T cells (Martin
et al., 2009), we investigated if these cells are competent in
IL-17 expression at the time of thymic maturation. We found
that gd T cells derived from IL-23-deficient embryonic thymus
had amounts of IL-17-expressing cells comparable to that
derived from WT. Thus, TLR2 and IL-23 are not critical for early
IL-17-producing gd T cell development but appear to be critical
in proliferation or maintenance of IL-17-producing gd T cells.
TLR2 Deficiency Reduces Th17 Generation In Vivo
and Confers Protection against EAE
To evaluate the direct role of TLR2 signaling in the regulation of
Th17 cells in vivo, Rag1/ mice were reconstituted with WT or
TLR2-deficient bone marrow and EAE was induced. In this
manner, we were able to assess the role of TLR2 directly in the
lymphoid compartment. Mice reconstituted with WT bone
marrow cells exhibited substantially higher disease severity
compared to animals reconstituted with Tlr2/ bone marrow;
however, disease incidence was similar between the two groups
because all mice developed disease (Figure 6A). Additional696 Immunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc.examination of CNS tissues revealed
reduced brain and spinal cord infiltration
with concomitant decreases of CD4 and
CD11b positive cells in animals reconsti-
tuted with Tlr2/ bonemarrow cells (Fig-
ure 6B). Interestingly, the result obtained
here is not in entire accordance with two
other reports (Chen et al., 2009; Prinz
et al., 2006) that utilized germline TLR2-
deficient animals in their EAE experi-
ments. These authors did not observe
differences in EAE severity or incidence
in Tlr2/ animals compared to WT con-
trols. Because all of our mice that were reconstituted with
Tlr2/ bone marrow did, in fact, develop disease, these studies
are not altogether different except for our observed decrease in
disease severity. Additional effects of TLR2 on nonlymphoid
cells may account for this discrepancy.
IL-17 plays a major role in pathogenesis of EAE (Dong,
2006). To investigate the role of TLR2 in the generation of
Th17 along with other Th subsets in vivo, we restimulated
CNS-infiltrating CD4+ T cells with PMA plus ionomycin. CNS
tissues derived from WT mice exhibited higher numbers of
IL-17 single and IL-17-IFNg double-positive cells (Figure 6B).
However, in terms of frequency, only IL-17+ cells were sub-
stantially decreased in Tlr2/ reconstituted mice (Figure 6C),
suggesting that Th17, not Th1, function is more dependent
on TLR2 activity. Splenocytes derived from EAE mice were
also evaluated for the generation of antigen-specific T cell
responses by MOG recall assays (Figure 6D). We found that
IL-17 production was substantially decreased in Tlr2/ sple-
nocytes compared with WT cells following MOG restimulation
in a dose-dependent manner. However, as was observed in
the CNS, no differences were observed in IFNg production.
Proliferation was assessed upon MOG restimulation as well.
We found that TLR2 deficiency resulted in a reduction of
antigen-specific T cell division following MOG immunization.
Taken together, our data indicate that Th17 generation
Figure 5. Analysis of WT, Tlr2/, and Il23a/ gd T Cells
(A) Splenic (left) or fetal thymic (right) gd T cells derived fromWT (top) or Tlr2/
(bottom) animals were stimulated with PMA plus ionomycin for 5 hours and
stained for IL-17 and IFNg production. Embryos were harvested from timed
breeders following day 18.5 post-vaginal plug observation.
(B) IL-17 production was investigated in gd T cells derived fromWT or Il23a/
spleens (left), lungs (center), and fetal thymi (right). Data presented are repre-
sentative of multiple experiments. gd T cells were isolated, and intracellular
cytokine staining was assessed following 5 hour PMA plus ionomycin stimula-
tion. Data are representative of at least two experiments, using at least two
mice per group.
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naling in lymphoctes.
TLR2 Deficiency in CD4+ T Cells Impairs
Pathogenesis of EAE
Our previous results demonstrated a role of the TLR2 pathway in
the development of Th17 responses during autoimmunity. To
directly delineate the function of TLR2 specifically on CD4+
T cells in vivo, we transferred total CD4+ T cells from WT and
TLR2-deficient animals into Rag1-deficient animals and induced
EAE. As observed with bone marrow-reconstituted animals, we
found that mice receiving Tlr2/ CD4+ T cells exhibited greatly
reduced disease severity compared to mice receiving WT
CD4+ T cells (Figure 7A). In contrast to bone marrow-reconsti-tuted EAE mice where there was no difference in disease inci-
dence, mice transferred with Tlr2/ CD4+ T cells exhibited little
to no disease across multiple experiments.
Next, we investigated CNS infiltration and cytokine production
in EAE mice. We found substantial decreases in total, CD4+, and
CD11b+ infiltrates into the CNS tissues of animals receiving
Tlr2/ CD4+ T cells (Figure 7B). Both IL-17 and IFNg positive
cells were decreased in mice with Tlr2/ T cells; however, no
difference was observed in total IL-17-IFNg double-positive
populations. Recent publications have indicated the importance
of gd T cells in the development of EAE (reviewed in (Blink and
Miller, 2009). Therefore, we tested spleen tissues of CD4+
T cell-transferred mice; however, gd T cells as well as B and
CD8+ T cells were completely absent in the spleen of both sets
of animals (data not shown), which rules out a possible role of
gd T cell TLR activation in this experiment.
To further investigate the mechanisms of EAE protection
observed in mice reconstituted with TLR2-deficient CD4+
T cells, we analyzed mRNA expression in the CNS tissues of
three individual mice from each group. Almost all Th17-related
genes were downregulated in the CNS of mice reconstituted
with TLR2-deficient CD4+ T cells, compared to those reconsti-
tuted with WT cells, with a substantial reduction observed for
IL-17 and IL-17F transcripts (Figure 7C). Additionally, WT cell-
reconstituted mice had higher expression of chemokines with
established roles in EAE, such as CCL2 and CCL20, than those
with TLR2-deficient T cells, providing a mechanistic basis for the
reduction in CD4+ and CD11b+ infiltrates observed in TLR2-
deficient reconstituted mouse CNS. Interestingly, IFNg mRNA
was greatly reduced in TLR2-deficient cell-reconstituted CNS
tissues, which may be secondary to the Th17 defect in these
mice, as Th17 cells are also important for migration of Th1 cells
into CNS (Yamazaki et al., 2008). Moreover, no differences were
observed in CNS cell staining for Foxp3 or in Foxp3 mRNA
expression (data not shown). IL-4 and IL-10 were undetectable
in the CNS tissues of both groups of mice (data not shown), indi-
cating that TLR2 deficiency might not alter Th2 or regulatory
T cell behavior.
To address the possibility that EAE pathogenesis may be influ-
enced directly by endogenous TLR2 ligands generated in vivo,
we induced EAE in Rag1-deficient mice reconstituted with WT
and Tlr2/ CD4+ T cells through the use of LPS rather than
CFA as an adjuvant (Figure 7D). We found that mice receiving
Tlr2/ T cells still exhibited a pronounced decrease in EAE
severity and incidence with only 55.5% of Tlr2/-reconstituted
mice developing disease compared to 100% of WT CD4-recon-
stituted mice. However, this difference in EAE incidence and
severity was moderate compared to EAE using CFA as an
adjuvant (Figure 7A). Thus, endogenous TLR2 ligands may be
important in the EAE pathogenesis, although TLR2 activation
may not be required for the initial activation and maintenance
of antigen-specific T cells in this model.
To further assess the direct role of TLR2 in Th17 cell differen-
tiation in vivo, we immunized Rag1-deficient mice with keyhole
limpet hemocyanin (KLH) reconstituted with both total WT or
Tlr2/ CD4+ T cells and WT B cells as we recently described
(Nurieva et al., 2009). Seven days later, draining lymph nodes
were then harvested and stained for IL-17 following culture
with KLH. WT T cell-transferred mice exhibited higher numbersImmunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc. 697
Figure 6. Assessment of EAE in Tlr2/
Bone Marrow-Reconstituted Mice
(A) Clinical score data comparing EAEmice recon-
stituted with WT or TLR2-deficient bone marrow.
Data are representative of three individual experi-
ments, n = 3–5 mice per group per experiment.
(B) CNS infiltration analysis of the bone marrow-
reconstituted mice presented in (A). Total infil-
trating CNS and splenic cell counts are presented
in the left panel. Analysis of CNS-infiltrating CD4+,
CD11b+, IL-17+, and IFNg+ are presented in the
right panel following 5 hour PMA plus ionomycin
restimulation.
(C) Representative CNS intracellular cytokine
staining of WT and Tlr2/ bone marrow-reconsti-
tutedmice following five-hour PMAplus ionomycin
restimulation (left). The right panel is a comparison
of the percentage of cytokine-positive cells of all
the mice analyzed. n = 5 per group.
(D) Splenic MOG recall assays. Splenocytes
derived from each group were restimulated with
MOG peptide for 3 days, and cytokine production
was assessed by ELISA (left and center). Prolifera-
tionwas examined following 3 dayMOG restimula-
tion and an 8 hour 3H-thymidine pulse (right). Data
are presented as mean ± SD for triplicate determi-
nations. *Student’s t test; p < 0.05.
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T cells (Figure 7E). No statistically significant differences were
observed in IFNg-positive cells. In addition, we also performed
a competitive experiment by immunizing WT and Tlr2/ mixed
bone marrow chimera mice with KLH. WT and Tlr2/ T cells
were then purified based on their congenic markers and
assessed for their cytokine expression following antigen restim-
ulation. Although no differences were observed in the homeo-
static proliferation of WT or Tlr2/ T cells before immunization
(data not shown), KLH restimulation revealed a decrease of
Tlr2/ IL-17-producing cells in draining lymph nodes (Fig-
ure 7F). Consistent with previous results, the production of
IFNg was not statistically different between the two groups.
Thus, TLR2 seems to regulate early Th17 differentiation in vivo.698 Immunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc.DISCUSSION
TLRs play crucial roles in the regulation of
innate immune responses. The enhance-
ment of TLR2 expression in Th17 cells
suggests an unexpected role of these
evolutionarily conserved receptors in di-
rect regulation of adaptive immunity.
TLR2, a pattern recognition receptor
that binds a wide variety of bacterial
products such as lipopeptides (Kawai
and Akira, 2007) thus became the focus
of this investigation; however, other
TLRs were increased in this subset as
well. Both TLR1 and TLR6 are dependent
on TLR2 for their cell surface expression
(Schumann and Tapping, 2007), so their
increased expression in Th17 cells mayallow increased TLR2 downstream activity in T cells. TLR4
expression was also upregulated in Th17 cells, suggesting
a functional relationship with IL-17 production that was previ-
ously discovered in gd T cells (Martin et al., 2009). Indeed, fully
differentiated Th17 cells restimulated with LPS and IL-23 ex-
hibited increased IL-17 responses as well. Thus, TLR4 signaling
may represent another pathway modulating the function of T
helper cells.
Our data show that TLR2 stimulation of highly purified CD4+
T cells during the Th17 differentiation process resulted in
increased proliferation and IL-17 production. Previous work
has suggested that TLR2 enhances the proliferative capacity of
both activated and memory CD4+ and CD8+ T cells (Cottalorda
et al., 2006; Komai-Koma et al., 2004; Mercier et al., 2009).
Figure 7. Assessment of EAE Development and Th17 Differentiation by Tlr2/ CD4+ T Cells
(A) Clinical scores of EAEmice that were transferredwithWT or Tlr2/CD4+ T cells. Data are a representative of two individual experiments with fivemice utilized
per group.
(B) Examination of CNS infiltration following EAE induction. The top panel represents total cell infiltration, whereas the bottom panel represents the total numbers
of cytokine-positive cells following 5 hour PMA plus ionomycin reactivation.
(C) mRNA analysis of CNS tissues at day 17 following EAE initiation. Three mice per group were analyzed at day 17, and gene expression was normalized to the
expression of the reference gene b-actin.
(D) Rag1-deficient mice were reconstituted with CD4+ T cells derived from C57BL/6 (WT) or TLR2-deficient mice. Clinical scores were monitored daily following
EAE induction with LPS emulsified in IFA and MOG. Fractions on the right represent mice developing EAE out of total mice analyzed.
(E) IL-17- and IFNg-positive cells in the draining lymph nodes of Rag1/mice transferred with WT or Tlr2/ CD4+ T cells following 7 day KLH immunization and
3 day KLH reactivation.
(F) IL-17 and IFNg cytokine production was measured by ELISA in bone marrow chimeric mice following 7 day KLH immunization. CD45.1 (WT) versus
CD45.2 (Tlr2/) CD4+ T cells were sorted and cultured with irradiated WT splenocytes and 50 mg/ml KLH for 3 days prior to cytokine assessment. *Student’s
t test; p < 0.05. Data are a representative of at least two individual experiments.
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TLR2 Regulates Th17 ResponsesHerein, we have demonstrated that even in the absence of TCR
activation, naive T cells are strongly influenced by TLR2 signals
as well. The proliferative effect of TLR2 activation observed on
Th17 cells in vitro could in theory affect homeostasis and main-
tenance of Th17 and other IL-17-producing cells in vivo. This
idea is supported by the reduced numbers of IL-17+ gd T cells
observed in Tlr2/ mice. Alternatively, TLR2 activation is not
sufficient to influence IL-17 production by itself in naive CD4+
T cells. In the case of Th17 differentiation, TCR activation along
with TGFb and IL-6 are also necessary for lineage commitment.
Likely, the increased IL-17 production observed in Th17 cells
differentiated in the presence of a TLR2 agonist is because of
a costimulatory effect in the differentiation of Th17 cells. This
additional TLR2 signal, in conjunction with TCR activation, may
also directly target the Th17-related transcription factors
RORg, RORa, or IRF-4 to aid in the production of IL-17. Interest-
ingly, no major effect was observed on other Th subset-related
transcription factors, such as T-bet and GATA-3, suggesting
that the TLR2 signaling selectively targets factors crucial forTh17 cells rather than inhibiting the alternative Th subsets. The
effect of TLR2 activation was assessed on Th1 and Th2 cells
as well; however, whereas proliferation differences were ob-
served, there was no effect on the production of IFNg or IL-4,
respectively (data not shown).
IL-17 production by CD4+ T cells was found to be strongly
affected by TLR2, even after the early stages of lineage commit-
ment. Fully differentiated Th17 cells treated with a TLR2 agonist
were still found to produce increased amounts of IL-17 and IL-22
proteins following TLR2 ligand restimulation, even when the TCR
stimulus was removed. However, the addition of IL-23 in combi-
nation with Pam3Cys resulted in a synergistic increase of both
IL-17 and IL-22 compared to Pam3Cys-treated alone. The
synergy we observed between TLR2 and IL-23 on Th17 cells
suggested that these mediators may be sufficient and TCR acti-
vation may not be required for fully committed Th17 memory
cells to produce IL-17. Indeed, we found that treatment of
CD4+ memory cells with Pam3Cys and IL-23 induced a small
amount of IL-17 expression even without TCR stimulation.Immunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc. 699
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TLR2 Regulates Th17 ResponsesAdditionally, naive and memory CD4+ cells both proliferated in
response to Pam3Cys alone. Thus, our results suggest a unique
pathway for maintenance of CD4+ Th17 populations, one that
requires only external or endogenous TLR2 stimuli.
gd T cells can produce substantial amounts of IL-17 depend-
ing on TCR specificity and the environment (O’Brien et al., 2009).
Moreover, during Mycobacterium tuberculosis (TB) infection, gd
T cells were found to be a predominant source of IL-17 in both
humans and mice (Lockhart et al., 2006; Peng et al., 2008).
Because of the prevalence of TLR ligands during TB infection,
coupled with the TLR2-IL-23 effect observed on ab T cells, we
investigated the role of TLR2 on IL-17-producing gd T cells. In
concurrence with a recent report (Martin et al., 2009), we found
that although TLR2 activation alone did not induce IL-17 produc-
tion from gd T cells, the addition of IL-23 induced enhanced IL-17
responses compared to cells treated with IL-23 alone. Likewise,
as was observed for naive and memory CD4+ T cells, TLR2
activation was sufficient to induce proliferation, whereas IL-23
had little to no effect on gd T cells. Taken together, our results
illustrate a mechanism of gd T cell IL-17 production. gd T cells
have the ability to rapidly respond to TLR2 signals and produce
IL-17 when IL-23 is present in the environment. IL-23, in turn, can
be produced by innate cells, such as dendritic cells and macro-
phages, after TLR2 activation, setting up a scenario in which the
same TLR2 signal could potentially activate antigen-presenting
cells as well as gd T cells, whichmay provide a sufficient environ-
ment for a rapid IL-17 response against invading pathogens.
Rag1/mice reconstituted with TLR2-deficient bone marrow
exhibited decreases in EAE disease severity and in vivo Th17
generation in the EAE model, demonstrating the importance of
TLR2 expression during autoimmunity by lymphoid cells. A
recent report found that TLR2 in conjunction with poly(ADP-
ribose) polymerase 1 expression by macrophages promoted
CNS inflammation and IL-17 production during EAE (Farez
et al., 2009). However, it was not clear in our model whether
these effects were due to TLR2 expression on innate or adaptive
immune cells. Therefore, most importantly in this study, we
tested the EAE model in Rag1-deficient mice reconstituted
with only CD4+ T cells. Interestingly, we found an even greater
degree of protection against EAE in mice reconstituted with
TLR2-deficient CD4+ T cells compared to mice receiving total
Tlr2/ bone marrow. In the CD4+ transfer model of EAE, we
observed reduced IFNg production as well in the Tlr2/ cell-
transferred animals. We previously reported that in IL-17-
deficient animals, there was also a reduced Th1 response
(Yang et al., 2008a), indicating a role of IL-17 in Th1 priming.
However, we cannot completely rule out a role of TLR2 in Th1
cells. The results presented here clearly demonstrate that
TLR2 signaling in CD4+ cells is crucial in the pathogenesis of
autoimmune inflammatory disorders.
Of great interest was the result that demonstrated that
Rag1/mice reconstituted with Tlr2/ CD4+ T cells developed
greatly decreased EAE disease. However, Rag1/ mice recon-
stituted with Tlr2/ bone marrow developed EAE normally,
although with less severity, compared to WT controls. We do
not know the exact mechanism to explain this discrepancy.
Our current theory is that TLR2 activation in non-CD4+ cells in
certain cases may actually inhibit the development of Th17
responses through the production of mediators such as IL-12700 Immunity 32, 692–702, May 28, 2010 ª2010 Elsevier Inc.or even IL-10. Indeed, in some cases it has been shown that
TLR2 activation can suppress rather than promote CNS inflam-
mation (Stenzel et al., 2008). Therefore, in germline Tlr2/ or
Tlr2/ bonemarrow-reconstituted animals, lack of TLR2 activa-
tion in non-CD4+ cells may actually promote Th17-dependent
autoimmunity. So even though T cells in these mice have a defi-
ciency in Th17 differentiation and expansion, the lack of these
inhibitory signals allows these mice to initiate EAE. When CD4+
T cells are transferred into Rag1/ mice, though, this defect in
Th17 generation exhibited by Tlr2/ T cells is amplified; Tlr2/
T cells have a greatly reduced capacity expanding and differen-
tiating into Th17 cells compared to their B6 counterparts.
Overall, our results demonstrate a function of TLR2 in T cells in
the regulation of Th17 responses. TLR2, although traditionally
associated with rapid innate-type responses, can act to enhance
both the proliferation and IL-17 production by Th17, memory,
and gd T cells. Thus, our observations described here have
broadened the function of TLRs to the regulation of adaptive
immunity. Although whether human multiple sclerosis is initiated
through TLR2-dependent mechanisms is unknown, there are
possible endogenous TLR2 ligands present that may have an
effect on Th17 generation, function, and maintenance. Further
studies are needed to examine if antagonistic targeting of TLR2
pathway may lead to the treatment and prevention of IL-17-
related disorders, such as that seen in MS, arthritis, or colitis.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, TLR2/, B6SJL, andRag1/mice were purchased from The Jack-
son Laboratory. Il23a/ mice came from NIH Mutant Mouse Regional
ResourceCenters. Allmicewere housedunderSPFconditions at theUniversity
of TexasM.D. Anderson Cancer Center, Houston, Texas. All experiments were
performed with mice 6–10 weeks old with protocols approved by the Institu-
tional Animal Care and Use Committee of the M.D. Anderson Cancer Center.
T Cell Isolation and Differentiation
Naive CD4+ T cells were purified, activated, and analyzed as previously
described (Yang et al., 2008b). All antibodies utilized were purchased from
Bio X Cell. Additionally, Pam3Cys-Ser-(Lys)4-trihydrochloride (Pam3Cys)
(Alexis Biochemicals) or FSL-1 (Pam2CGDPKHPKSF) (Invivogen) was added
to some of the treatment groups. Memory CD4+ T cells (CD4+CD62Llo
CD44hiCD25) were derived from spleen and lymph nodes and then sorted
on a FACSAria. gd T cells were harvested from spleen, lung, and lymph nodes
and further purified using a gd T cell isolation kit and autoMACS (Miltenyi).
Thymus-derived, embryonic gd T cell were isolated in a similar manner from
timed breeders at g18.5. Gene expression analysis was performed with an
iCycler Optical System with IQ SYBR green from Bio-Rad. Gene expression
was normalized to the Actb reference gene. Specific primer sequences can
be found in Supplemental Experimental Procedures.
Bone Marrow Reconstitution
Bone marrow was harvested from WT (C57BL/6 or B6SJL) and Tlr2/ mice,
filtered, and washed 33 in PBS. Cells were then counted, and 5 3 106 cells
were injected in the tail veins of sub-lethally irradiated Rag1-deficient animals.
Sixweeksafter injection,micewerechecked for reconstitutionbybloodanalysis.
CD4+ T Cell Transfer
Total CD4+ T cell populations were isolated from the spleens and lymph nodes
of WT and TLR2-deficient animals. CD4+ T cells were further purified using
CD4 microbeads and autoMACS (Miltenyi). Cells were counted and washed
3X in PBS and then injected i.v. into tail veins of Rag1/mice at 53 106 cells
per animal. EAE was induced or KLH was immunized the day following CD4+
transfer.
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EAE disease was induced using CFA and analyzed as previously described
(Nurieva et al., 2007). For EAE induction using LPS, CD4+ cells were trans-
ferred to Rag1/ recipients. On the following day, mice were immunized
with MOG emulsified in IFA and LPS (Sigma, Escherichia coli O111:B4).
From this emulsion, each mouse received a total of 150 mg MOG peptide
and 30 mg LPS. Pertussis toxin and a second MOG immunization were admin-
istered as in the CFA adjuvant model. Clinical scores were as follows: 0, no
signs of disease; 1, tail paralysis; 2, wobbly gait; 3, hind limb paralysis; 4, fore-
limb paralysis; and 5, moribund or dead. 0.5 gradations were utilized on mice
exhibiting symptoms falling between two of the above listed scores.
Proliferation Analysis
For Th17 differentiation, cells were stained with CFSE (CFDA; Invitrogen) prior
to stimulation. Following 4 day differentiation, CFSE dilution was assessed
by flow cytometry. For MOG recall, splenocytes were incubated with 1, 5,
and 25 mg/ml MOG (Synbiosci) 3 days prior to 8 hour pulse with 3H-thymidine
(Amersham/GE Healthcare). Analysis (cpm) was performed on a Perkin Elmer
1450 Microbeta Liquid Scintillation Counter.
ELISA
Supernatants from primary differentiation, MOG-restimulated, or KLH-
restimulated cultures were harvested on days 4 and 3, respectively. Restimu-
lated cultures were harvested after overnight incubation. IL-17, IL-17F, and
IFNg cytokine production was assessed by ELISA kits (BD Biosciences and
R&D Systems).
KLH Immunization
For CD4+ T cell transfer experiments, total CD4+ T cells and B220+ B cells were
prepared from the lymph nodes and spleen of C57BL/6 and Tlr2/ mice by
autoMACs. Cells were washed 33 in PBS, and 5 3 106 WT or Tlr2/ CD4+
T cells were injected i.v. along with 5 3 106 B cells. On the following day,
mice were immunized with KLH (0.5 mg/ml) emulsified in CFA (0.5 mg/ml) at
the base of the tail (100 ml each mouse). Seven days after immunization, these
mice were sacrificed and draining lymph nodes were plated in the presence of
50 mg/ml KLH. Following 3 day incubation, cells were treated with Golgi Stop
(BDBiosciences) for 5 hours prior to intracellular cytokine staining for IL-17 and
IFNg. For the bone marrow reconstitution experiments, B6SJL (CD45.1) and
Tlr2/ (CD45.2) bone marrow was harvested and injected at a 1:1 ratio i.v.
into sub-lethally irradiated Rag1-deficient mice. Six weeks after reconstitution,
mice were immunized with KLH as described above. Draining lymph nodes
were then harvested, and CD45.1+ or CD45.2+ CD4+ T cells were sorted and
then stimulated with 50 mg/ml KLH for 3 days in the presence of irradiated
WT APCs. Supernatants were then assayed for ELISA (BD-PharMingen).
SUPPLEMENTAL INFORMATION
The Supplemental Information includes three figures and Supplemental Exper-
imental Procedures and can be found with this article online at doi:10.1016/j.
immuni.2010.04.010.
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